Fulgent Genetics Inc (FLGT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 12-2024 | 12-2023 | 12-2022 | 12-2021 | |
| Sales | 322,671 | 283,470 | 289,213 | 618,968 | 992,584 |
| Cost of Goods | 191,796 | 176,255 | 184,757 | 252,067 | 215,533 |
| Gross Profit | 130,875 | 107,215 | 104,456 | 366,901 | 777,051 |
| Operating Expenses | 222,767 | 181,388 | 300,742 | 188,441 | 101,631 |
| Operating Income | -91,096 | -73,918 | -195,529 | 178,527 | 675,953 |
| Interest Expense | 75 | -170 | 488 | 1,013 | 0 |
| Other Income | 21,146 | 21,792 | 21,932 | 6,511 | 5,081 |
| Pre-tax Income | -70,025 | -51,956 | -174,085 | 184,025 | 681,034 |
| Income Tax | -8,394 | -8,136 | 1,154 | 42,102 | 174,795 |
| Net Income Continuous | -61,631 | -43,820 | -175,239 | 141,923 | 506,239 |
| Minority Interests | -1,118 | -1,112 | -7,414 | -1,480 | -1,125 |
| Net Income | $-60,513 | $-42,708 | $-167,825 | $143,403 | $507,364 |
| EPS Basic Total Ops | -1.97 | -1.41 | -5.63 | 4.76 | 17.25 |
| EPS Basic Continuous Ops | -2.00 | -1.45 | -5.88 | 4.72 | 17.21 |
| EPS Diluted Total Ops | -1.97 | -1.41 | -5.63 | 4.63 | 16.38 |
| EPS Diluted Continuous Ops | -2.00 | -1.45 | -5.88 | 4.58 | 16.34 |
| EPS Diluted Before Non-Recurring Items | -0.74 | -0.67 | -1.55 | 5.04 | 16.38 |
| EBITDA(a) | $-72,076 | $-54,540 | $-53,063 | $215,956 | $694,553 |